vs
Side-by-side financial comparison of PureCycle Technologies, Inc. (PCT) and Sensus Healthcare, Inc. (SRTS). Click either name above to swap in a different company.
Sensus Healthcare, Inc. is the larger business by last-quarter revenue ($4.9M vs $2.7M, roughly 1.8× PureCycle Technologies, Inc.). Sensus Healthcare, Inc. runs the higher net margin — -64.1% vs -697.1%, a 633.0% gap on every dollar of revenue. Sensus Healthcare, Inc. produced more free cash flow last quarter ($-2.4M vs $-42.0M).
PureCycle Technologies, Inc. is a sustainable materials firm with proprietary advanced polypropylene recycling technology. It converts contaminated polypropylene waste into high-purity virgin-equivalent resin for use in consumer goods, automotive parts, packaging and industrial products, serving global partners.
Sensus Healthcare, Inc. is a medical technology company that designs, manufactures and commercializes innovative non-invasive superficial radiation therapy systems. Its products are primarily used for treating non-melanoma skin cancers, keloids, and select cosmetic dermatology conditions, serving healthcare providers and clinical facilities worldwide.
PCT vs SRTS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.7M | $4.9M |
| Net Profit | $-18.8M | $-3.2M |
| Gross Margin | — | 38.4% |
| Operating Margin | -2196.1% | -63.8% |
| Net Margin | -697.1% | -64.1% |
| Revenue YoY | — | -62.2% |
| Net Profit YoY | 71.0% | -304.9% |
| EPS (diluted) | $-0.14 | $-0.19 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.7M | $4.9M | ||
| Q3 25 | $2.4M | $6.9M | ||
| Q2 25 | $1.6M | $7.3M | ||
| Q1 25 | $1.6M | $8.3M | ||
| Q4 24 | $0 | $13.1M | ||
| Q3 24 | $0 | $8.8M | ||
| Q2 24 | $0 | $9.2M | ||
| Q1 24 | $0 | $10.7M |
| Q4 25 | $-18.8M | $-3.2M | ||
| Q3 25 | $-28.4M | $-943.0K | ||
| Q2 25 | $-144.2M | $-1.0M | ||
| Q1 25 | $8.8M | $-2.6M | ||
| Q4 24 | $-64.7M | $1.5M | ||
| Q3 24 | $-90.6M | $1.2M | ||
| Q2 24 | $-48.2M | $1.6M | ||
| Q1 24 | $-85.6M | $2.3M |
| Q4 25 | — | 38.4% | ||
| Q3 25 | — | 39.4% | ||
| Q2 25 | — | 39.7% | ||
| Q1 25 | — | 52.2% | ||
| Q4 24 | — | 54.4% | ||
| Q3 24 | — | 59.3% | ||
| Q2 24 | — | 58.7% | ||
| Q1 24 | — | 62.5% |
| Q4 25 | -2196.1% | -63.8% | ||
| Q3 25 | -1602.2% | -37.3% | ||
| Q2 25 | -2763.5% | -26.6% | ||
| Q1 25 | -2387.4% | -31.7% | ||
| Q4 24 | — | 13.2% | ||
| Q3 24 | — | 16.9% | ||
| Q2 24 | — | 21.5% | ||
| Q1 24 | — | 27.1% |
| Q4 25 | -697.1% | -64.1% | ||
| Q3 25 | -1167.5% | -13.7% | ||
| Q2 25 | -8741.8% | -14.2% | ||
| Q1 25 | 559.0% | -30.8% | ||
| Q4 24 | — | 11.8% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 17.4% | ||
| Q1 24 | — | 21.3% |
| Q4 25 | $-0.14 | $-0.19 | ||
| Q3 25 | $-0.31 | $-0.06 | ||
| Q2 25 | $-0.81 | $-0.06 | ||
| Q1 25 | $0.05 | $-0.16 | ||
| Q4 24 | $-0.40 | $0.10 | ||
| Q3 24 | $-0.54 | $0.07 | ||
| Q2 24 | $-0.29 | $0.10 | ||
| Q1 24 | $-0.52 | $0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $156.7M | $22.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $45.9M | $48.1M |
| Total Assets | $922.7M | $53.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $156.7M | $22.1M | ||
| Q3 25 | $234.4M | $24.5M | ||
| Q2 25 | $284.1M | $22.2M | ||
| Q1 25 | $22.5M | $19.1M | ||
| Q4 24 | $15.7M | $22.1M | ||
| Q3 24 | $83.7M | $22.6M | ||
| Q2 24 | $10.9M | $19.0M | ||
| Q1 24 | $25.0M | $14.7M |
| Q4 25 | $45.9M | $48.1M | ||
| Q3 25 | $68.2M | $51.2M | ||
| Q2 25 | $98.9M | $52.1M | ||
| Q1 25 | $238.2M | $53.0M | ||
| Q4 24 | $180.4M | $55.8M | ||
| Q3 24 | $241.4M | $54.1M | ||
| Q2 24 | $291.6M | $52.9M | ||
| Q1 24 | $336.8M | $51.2M |
| Q4 25 | $922.7M | $53.0M | ||
| Q3 25 | $989.1M | $58.3M | ||
| Q2 25 | $1.0B | $58.9M | ||
| Q1 25 | $787.3M | $60.2M | ||
| Q4 24 | $798.4M | $62.2M | ||
| Q3 24 | $788.8M | $59.9M | ||
| Q2 24 | $719.8M | $58.2M | ||
| Q1 24 | $734.0M | $57.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-28.7M | $-2.2M |
| Free Cash FlowOCF − Capex | $-42.0M | $-2.4M |
| FCF MarginFCF / Revenue | -1559.6% | -47.9% |
| Capex IntensityCapex / Revenue | 495.1% | 3.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-183.6M | $332.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-28.7M | $-2.2M | ||
| Q3 25 | $-38.5M | $2.3M | ||
| Q2 25 | $-36.7M | $3.1M | ||
| Q1 25 | $-38.9M | $-2.7M | ||
| Q4 24 | $-31.8M | $-827.0K | ||
| Q3 24 | $-33.4M | $4.0M | ||
| Q2 24 | $-40.4M | $4.2M | ||
| Q1 24 | $-39.2M | $-8.2M |
| Q4 25 | $-42.0M | $-2.4M | ||
| Q3 25 | $-42.4M | $2.3M | ||
| Q2 25 | $-45.3M | $3.1M | ||
| Q1 25 | $-53.9M | $-2.7M | ||
| Q4 24 | $-53.4M | $-1.1M | ||
| Q3 24 | $-42.6M | $3.6M | ||
| Q2 24 | $-50.8M | $4.2M | ||
| Q1 24 | $-53.5M | $-8.4M |
| Q4 25 | -1559.6% | -47.9% | ||
| Q3 25 | -1743.1% | 33.3% | ||
| Q2 25 | -2747.1% | 42.2% | ||
| Q1 25 | -3409.6% | -32.2% | ||
| Q4 24 | — | -8.6% | ||
| Q3 24 | — | 40.9% | ||
| Q2 24 | — | 45.8% | ||
| Q1 24 | — | -79.0% |
| Q4 25 | 495.1% | 3.2% | ||
| Q3 25 | 160.3% | 0.1% | ||
| Q2 25 | 521.5% | 0.4% | ||
| Q1 25 | 949.6% | 0.1% | ||
| Q4 24 | — | 2.3% | ||
| Q3 24 | — | 3.8% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 2.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -4.40× | — | ||
| Q4 24 | — | -0.53× | ||
| Q3 24 | — | 3.25× | ||
| Q2 24 | — | 2.62× | ||
| Q1 24 | — | -3.60× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PCT
Segment breakdown not available.
SRTS
| Products | $2.8M | 57% |
| Other | $2.1M | 43% |
